Investor_Relations
NOVUS strives to serve the communities and create values for our trustworthy and passionate investors.
NOVUS was established in 2014 with a clear mission to become a trailblazer in the realm of cutting-edge biomaterials for clinical applications. Over the years, we have dedicated ourselves to creating significant value for both our esteemed investors and society as a whole. During our formative stages, NOVUS received unwavering support from respected statutory bodies across various countries, in addition to investments from prominent angels and venture capitalists worldwide. These crucial partnerships have propelled us forward, allowing NOVUS to expand into a group of companies engaged in diverse activities such as biomaterials research and development, manufacturing, contract research, and technology consultancy. Our multifaceted roles enable us to stay at the forefront of the fast-paced technology landscape, continuously adapting to industry advancements.
With a solid foundation firmly in place, NOVUS remains committed to establishing a robust presence in the healthcare and technology sectors. We are driven by a relentless pursuit of innovation, leveraging our expertise and experience to deliver groundbreaking solutions. Our unwavering dedication to pushing boundaries and making a lasting impact sets us apart. As we move forward, we strive to further strengthen our position in the industry, driving transformative change and revolutionizing the intersection of healthcare and technology.
#Supporting_statutory_bodies, Partners_and_prizes
Ernst & Young
EY x Fosun Challenge, Shanghai, 2018 - NOVUS won in the EY x Fosun Challenge in Shanghai and won a pilot project with Fosun.
Fosun
EY x Fosun Challenge, Shanghai, 2018 - NOVUS won in the EY x Fosun Challenge in Shanghai and won a pilot project with Fosun.
Alibaba Jumpstarter
Jumpstarter is an entrepreneurship programme launched by Alibaba. In 2017, NOVUS won in the Healthcare stream.
CNBC
NOVUS was selected by CNBC as 20 of the world’s hottest start-ups of 2014.
Austria Wirtschaftsservice
AWS and FFG, the government technology and innovation agencies in Austria has selected NOVUS to join goAustria 2016.
e27
Asia’s Top 100 Issued by Echelon Asia Summit (e27).
https://e27.co/startup/novus-life-sciences-limited
https://e27.co/echelon/asia/top100
Hong Kong Science and Technology Parks
NOVUS is a graduate of HKSTP incu-bio programme in 2018. Ossfila is a graduate of HKSTP incu-tech programme in 2022.
Dreamcatchers, the University of Hong Kong
HKU Dreamcatchers has supported NOVUS and Ossfila to kick-start the commerilization of deep-tech biomaterial technologies.
Global Incubator Network Austria (GIN)
GIN is the connecting link between Austrian and international startups, investors, incubators and accelerators. NOVUS represented Hong Kong in 2016.
SOW Asia
NOVUS Life Sciences has been selected to join the Biotechnology and Wellbeing cohort of SOW Asia's i2i (Incubation to Investment) accelerator program.
ImagineIF
In 2016, Innovation Forum has selected NOVUS has the HONG KONG champion and Global top 15 to present in the University of Cambridge, UK.
French Tech Ticket
French Tech Ticket is a French national tech startup programme. In 2017, NOVUS has won the ticket and participated in the programme.
Innovation and Technology Commission, HKSARG
Innovation and Technology Commission has been supporting the R&D activities of NOVUS.
Global Entrepreneurship Week (GEW 50)
NOVUS was a GEW50 finalist in 2014.
IPIEC Global
The winner of the IPIEC Global 2018. NOVUS was ultimately awarded the annual global overall championship winning a reward of HK$780,000.
Innovation Forum
In 2016, Innovation Forum has selected NOVUS has the HONG KONG champion and Global top 15 to present in the University of Cambridge, UK.